Navinci strengthens leadership with new Director of Operations
Navinci Diagnostics AB announces the appointment of Sopana Leife as new Director of Operations, effective September 2nd 2024.
Andrea Ballagi joins Navinci Board of Directors
Navinci are pleased to announce the appointment of Andrea Ballagi to the board, bringing further leadership expertise to the Company.
Navinci Housewarming Party
Last Friday (May 3), Navinci had the absolute pleasure of hosting a housewarming party to celebrate the grand opening of our new office, with a fantastic turnout.
Navinci expands into new facilities
Navinci celebrates a milestone, relocating to Uppsala Science Park, bolstering R&D capabilities. The move reflects continued growth and commitment to pioneering spatial proteomics.
Navinci and 2BScientific announce a strategic partnership
Navinci partners with 2BScientific, UK’s premier life sciences distributor, expanding reach for spatial proteomics assays, benefiting researchers with innovative solutions in the UK.
Navinci joins Milner Therapeutics Institute Affiliated Company scheme
Navinci joins the Milner Therapeutics Institute Affiliated Company scheme, fostering collaboration among academic, pharmaceutical, and biotech partners to advance research and innovation.
Assay database alert! E-cadherin/β-catenin added
Explore our assay database’s new addition: E-cadherin/β-catenin interactions’ impact on cell adhesion and cancer progression, illuminating critical biological processes.
Exciting news: Explore our dynamic assay database!
Introducing our newest feature – the assay database, with demonstrated assays and protocols for targeted protein-protein interactions and specific protein detection!
Exciting Times in the World of Proteomics!
Thermo Fisher Scientific’s remarkable $3.1 billion acquisition of Olink Proteomics is a testament to the incredible technology that forms the foundation of Olink Proteomics.
Expanding our reach – new distribution partnership in Italy
Navinci is excited to announce a distribution collaboration with EuroClone, a strategic move aimed at advancing our global sales expansion efforts.
New Research Unveils p53 Aggregates’ Vital Role in Ovarian Cancer Prognosis and Treatment Strategies
The authors used the NaveniFlex™ assay and we are proud our research tools proved to be of great importance in ovarian cancer research.
Discover the secret life of proteins – concurrently visualize two proteins in a free and complex state
Discover the secret life of proteins – simultaneously visualize two proteins in a free and complex state Ever wish there were a way to take a snapshot of two proteins as they interact or remain unbound? Now, the door is open to study protein interplay and functional states while keeping the structural integrity of cells.…